相关实验视频
Updated: Jun 11, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
糖尿病技术协会错误网格和葡萄糖监测器趋势准确度矩阵
David C Klonoff1, Guido Freckmann2, Stefan Pleus2
1Diabetes Research Institute, Mills-Peninsula Medical Center, San Mateo, CA, USA.
Journal of diabetes science and technology
|October 6, 2024
概括
一个新的糖尿病技术协会 (DTS) 错误网格改进了血糖监测器 (BGM) 和连续血糖监测器 (CGM) 的血糖监测准确性评估. 该工具通过为葡萄糖读数提供更清晰的风险区域来增强临床决策.
科学领域:
- 内分泌学 在内分泌学.
- 医疗器械 医疗器械
- 生物医学工程 生物医学工程
背景情况:
- 血糖监测器 (BGM) 的传统错误网格在评估连续血糖监测器 (CGM) 的临床准确性方面存在局限性.
- 现有的方法不能充分反映CGM性能在现实世界的葡萄糖监测场景的细微差别.
研究的目的:
- 开发一个统一和用户友好的错误网格,用于评估BGM和CGM的准确性.
- 建立适用于这两种设备类型的标准化风险区 (A-E).
- 为评估CGM趋势准确性创建一个新的矩阵.
主要方法:
- 召集了89名国际专家,将监控错误网格 (SEG) 改进为DTS错误网格.
- 定义了五个风险区 (A-E),直线边界为准确点.
- 分析了22个BGM和9个CGM准确性研究,以将DTS错误网格区域A性能与平均绝对相对差异 (MARD) 相关联.
- 开发了一个DTS趋势准确度矩阵,其中包括CGM趋势指标的五个类别.
主要成果:
- DTS错误网格提供了一个用户友好的工具,用于BGM和CGM点精度,具有标准化的风险区域.
- 分析显示了直接关系:A区数据的1%增加对应于MARD的0.33%下降.
- DTS趋势准确度矩阵为评估CGM趋势准确度提供了一种新方法.
结论:
- DTS错误网格有效地整合了评估BGM和CGM点精度的临床输入.
- DTS趋势准确度矩阵为CGM趋势指标准确度提供了有价值的评估.
- 这些工具旨在提高血糖监测设备的临床实用性和安全性.
相关概念视频
Errors occurring during blood pressure monitoring
607
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
607
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Hypoglycemia and Glucagon
206
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
206

